Partnership
Fujifilm Partners with Dr. Reddy's and Global Response Aid for Deployment of a COVID-19 Treatment Drug Outside of Japan
Nice Insight
PR-M06-20-NI-043Jul 02, 2020
Launch
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Powder for Oral Solution, USP in the U.S. Market
Dr. Reddy's Laboratories
PR-M08-19-NI-070Aug 23, 2019
Biosimilar
Dr. Reddy's Laboratories Announces the Launch of Versavo® (bevacizumab biosimilar) in India
Dr. Reddy's Laboratories
PR-M08-19-NI-063Aug 22, 2019
Announcement
Court Ruling in Favor of Aquestive Therapeutics Enjoining Dr. Reddy's Laboratories from Launching its Generic Suboxone Product
Aquestive Therapeutics
PR-M07-18-NI-053Jul 17, 2018
FDA Approval
Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
Dr. Reddy's Laboratories
PR-M06-18-NI-063-4098Jun 19, 2018
NDA
Dr. Reddy's Laboratories and its U.S. subsidiary Promius Pharma announce the filing of an NDA for its migraine candidate
Dr. Reddy's Laboratories
PR-M04-18-NI-019Apr 05, 2018
Licensing
Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology
Dr. Reddy's Laboratories
PR-M08-17-NI-005Aug 22, 2017